CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 1 filers reported holding CATALYST BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,936 | +328.3% | 4,017 | +212.6% | 0.00% | – |
Q2 2023 | $452 | – | 1,285 | -6.7% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 1,377 | -1.2% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 1,394 | -32.9% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 2,076 | +75.3% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,184 | -62.7% | 0.00% | – |
Q1 2022 | $2,000 | -85.7% | 3,175 | +15.5% | 0.00% | – |
Q1 2021 | $14,000 | 0.0% | 2,748 | +22.8% | 0.00% | – |
Q4 2020 | $14,000 | -82.3% | 2,238 | -87.8% | 0.00% | -100.0% |
Q3 2020 | $79,000 | +19.7% | 18,326 | +61.9% | 0.00% | -66.7% |
Q2 2020 | $66,000 | +725.0% | 11,322 | +585.8% | 0.00% | – |
Q1 2020 | $8,000 | -55.6% | 1,651 | -38.6% | 0.00% | -100.0% |
Q4 2019 | $18,000 | – | 2,688 | +3062.4% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 85 | -97.9% | 0.00% | -100.0% |
Q2 2019 | $29,000 | +2800.0% | 4,037 | +2288.8% | 0.00% | – |
Q1 2019 | $1,000 | -90.0% | 169 | -81.8% | 0.00% | -100.0% |
Q3 2018 | $10,000 | +150.0% | 931 | +148.9% | 0.00% | – |
Q2 2018 | $4,000 | – | 374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
22NW, LP | 735,841 | $4,319,000 | 2.34% |
Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |